The effect of the COVID-19 pandemic on alcohol use and psycho-somatic health in pregnant and postpartum women with intersecting vulnerabilities.
- Funded by National Institutes of Health (NIH)
- Total publications:0 publications
Grant number: 3R01AA021771-08S1
Grant search
Key facts
Disease
COVID-19Start & end year
20132023Known Financial Commitments (USD)
$134,896Funder
National Institutes of Health (NIH)Principal Investigator
Ludmila Nicole BakhirevaResearch Location
United States of AmericaLead Research Institution
University Of New Mexico Health Scis CtrResearch Priority Alignment
N/A
Research Category
Clinical characterisation and management
Research Subcategory
Prognostic factors for disease severity
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Adults (18 and older)
Vulnerable Population
Pregnant women
Occupations of Interest
Unspecified
Abstract
SUMMARY/Abstract: The new clinical guidelines for diagnosing Fetal Alcohol Spectrum Disorders (FASD) list self-regulation as oneof the key behavioral deficits in children affected by prenatal alcohol exposure (PAE). There is a fundamentalgap in knowledge about the underlying mechanisms, spectrum, and severity of such deficits early in life and thebest analytical approaches to identify them. In addition, the effect of prenatal stress and postnatal environmenton PAE-induced alterations is poorly understood. The primary focus of the parent Ethanol, Neurodevelopment,Infant, and Child Health 2 (ENRICH-2) study is on identification of neurobehavioral deficits associated with PAEearly in life. This administrative supplement will allow us to examine the comorbid effect of COVID-19 pandemicand alcohol use on adverse maternal and infant outcomes in this cohort. The long-term goal of this supplementis to characterize the psycho-social effect of COVID-19 pandemic on adverse outcomes, including alcohol use,in a longitudinal birth cohort study, thus providing the foundation for future intervention studies. The objective ofthis supplement is to comprehensively evaluate the effect of COVID-19 related stress in pregnant andpostpartum women enrolled in the ENRICH-2 cohort. We will evaluate this by adding state-of-the-art self-reported measures integrated with real-time physiological data that are not currently part of the funded parentstudy. The rationale for this supplement is driven by the gap in knowledge about the effect of the COVID-19pandemic on psychosocial outcomes, alcohol use, and stress-related physical outcomes in pregnant andpostpartum women, a vulnerable population disproportionately affected. We will address this gap in knowledgeby pursuing two specific aims which evaluate the effect of COVID-19 on adverse maternal and infant outcomesin the ENRICH-2 cohort: 1) psychosocial outcomes and alcohol use, assessed as COVID-19 stress related toexposures and symptoms, COVID-19 pandemic adjustment, emotion regulation, mother-infant attachment, andalcohol consumption and 2) physiologic outcomes assessed as heart rate variability and sleep patterns,evaluated by wearable electronics - an approach particularly novel in the current social distancing environment.This approach is highly innovative, and will allow for the objective, real-time data collection in the climate ofprolonged social distancing and challenges associated with face-to-face research visits in vulnerablepopulations. A detailed characterization of COVID-19 related outcomes in pregnant and postpartum women,effect of COVID-related social isolation and other hardships on mental health and alcohol use, as well as thecumulative effect on pediatric neurodevelopmental outcomes are highly significant in order to lay out thefoundation for early effective interventions to mitigate the effects in these vulnerable populations.